Maqola

POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment

Olga KuleminaMemorial Sloan Kettering Cancer Center, New York, USAJulia YakovlevaRussian Research Institute of Hematology and Transfusiology, St. Petersburg, Russian FederationNatalia LazorkoRepublican Specialized Hematological Scientific and Practical Medical Center, Tashkent, Uzbekistan, Tashkent, UzbekistanTamara ChitanavaImperial College London, London, United KingdomNadia SiordiaImperial College London, London, United KingdomNadezhda ShnalievaAlmazov National Medical Research Centre, St. Petersburg, Russian FederationElena TochenayaRepublican Specialized Hematological Scientific and Practical Medical Center, Tashkent, UzbekistanPolina MateikovichAlmazov National Medical Research Centre, St. Petersburg, Russian FederationElza LomaiaImperial College London, London, United Kingdom

Clinical Lymphoma Myeloma & Leukemiajournal2023en

Ochiq kirish: yoʻq

ABI

Annotatsiya

Annotatsiya mavjud emas.

Mavzular

Chronic Myeloid Leukemia Treatments Myeloproliferative Neoplasms: Diagnosis and Treatment Chronic Lymphocytic Leukemia Research

Identifikatorlar

DOI: 10.1016/s2152-2650(23)00571-2

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba